Spain: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Spain

For the third year in a row, the Spanish prophylactic medicaments containing insulin market recorded decline in sales value, which decreased by -0.1% to $X in 2022. The market value increased at an average annual rate of +3.4% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. As a result, consumption attained the peak level of $X. From 2015 to 2022, the growth of the market failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Spain

In value terms, prophylactic medicaments containing insulin production reached $X in 2022 estimated in export price. Over the period under review, the total production indicated a perceptible expansion from 2012 to 2022: its value increased at an average annual rate of +3.1% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by -0.1% against 2020 indices. The most prominent rate of growth was recorded in 2014 with an increase of 68%. As a result, production attained the peak level of $X. From 2015 to 2022, production growth failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Spain

In 2022, shipments abroad of medicaments containing insulin but not antibiotics in measured doses decreased by -12.3% to X tons for the first time since 2018, thus ending a three-year rising trend. In general, exports, however, enjoyed a significant increase. The pace of growth appeared the most rapid in 2015 with an increase of 6,068%. Over the period under review, the exports hit record highs at X tons in 2016; however, from 2017 to 2022, the exports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin exports fell to $X in 2022. Over the period under review, exports, however, posted a significant expansion. The growth pace was the most rapid in 2015 when exports increased by 2,815%. Over the period under review, the exports reached the maximum at $X in 2016; however, from 2017 to 2022, the exports failed to regain momentum.

Exports by Country

Germany (X tons), France (X tons) and South Korea (X tons) were the main destinations of prophylactic medicaments containing insulin exports from Spain, with a combined 53% share of total exports. Italy, the UK, Taiwan (Chinese), Turkey, the Philippines, Israel, Belgium, the Czech Republic, Brazil and Sweden lagged somewhat behind, together comprising a further 40%.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by the Czech Republic (with a CAGR of +76.5%), while the other leaders experienced more modest paces of growth.

In value terms, the largest markets for prophylactic medicaments containing insulin exported from Spain were Germany ($X), France ($X) and Italy ($X), with a combined 59% share of total exports. South Korea, the UK, Belgium, Israel, the Czech Republic, Sweden, Taiwan (Chinese), the Philippines, Turkey and Brazil lagged somewhat behind, together comprising a further 34%.

In terms of the main countries of destination, the Czech Republic, with a CAGR of +58.6%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, increasing by 1.7% against the previous year. Overall, the export price, however, recorded a mild slump. The most prominent rate of growth was recorded in 2014 when the average export price increased by 77%. As a result, the export price reached the peak level of $X per ton. From 2015 to 2022, the average export prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the Czech Republic ($X per ton), while the average price for exports to Turkey ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Sweden (+5.0%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Spain

In 2022, overseas purchases of medicaments containing insulin but not antibiotics in measured doses decreased by -9.7% to X tons, falling for the third consecutive year after four years of growth. Over the period under review, imports recorded a pronounced setback. The most prominent rate of growth was recorded in 2014 when imports increased by 20%. Imports peaked at X tons in 2019; however, from 2020 to 2022, imports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin imports expanded to $X in 2022. Overall, imports showed a abrupt descent. The pace of growth was the most pronounced in 2014 when imports increased by 25% against the previous year. As a result, imports attained the peak of $X. From 2015 to 2022, the growth of imports remained at a lower figure.

Imports by Country

In 2022, Germany (X tons) constituted the largest supplier of prophylactic medicaments containing insulin to Spain, accounting for a 57% share of total imports. Moreover, prophylactic medicaments containing insulin imports from Germany exceeded the figures recorded by the second-largest supplier, France (X tons), twofold. The third position in this ranking was held by the United States (X tons), with an 8.5% share.

From 2012 to 2022, the average annual growth rate of volume from Germany was relatively modest. The remaining supplying countries recorded the following average annual rates of imports growth: France (+9.1% per year) and the United States (+109.3% per year).

In value terms, the largest prophylactic medicaments containing insulin suppliers to Spain were the United States ($X), France ($X) and Germany ($X), together accounting for 90% of total imports.

The United States, with a CAGR of +116.8%, saw the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, surging by 13% against the previous year. In general, the import price, however, recorded a abrupt slump. The import price peaked at $X per ton in 2014; however, from 2015 to 2022, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was the United States ($X per ton), while the price for Germany ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (+11.0%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :